MADRIGAL PHARMACEUTICALS INC's ticker is and the CUSIP is 558868955. A total of 5 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,375,572 | +33.7% | 194,300 | +111.4% | 0.01% | +28.6% |
| Q2 2023 | $21,228,900 | +66.3% | 91,900 | +74.4% | 0.01% | +40.0% |
| Q1 2023 | $12,767,102 | -65.8% | 52,700 | -59.1% | 0.01% | -70.6% |
| Q4 2022 | $37,384,200 | +1359.8% | 128,800 | +226.9% | 0.02% | +1600.0% |
| Q3 2022 | $2,561,000 | -1.4% | 39,400 | +8.5% | 0.00% | 0.0% |
| Q2 2022 | $2,598,000 | – | 36,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 129,400 | $18,897,576 | 0.06% |
| JANE STREET GROUP, LLC | 194,300 | $28,375,572 | 0.01% |
| SIMPLEX TRADING, LLC | 15,200 | $2,219 | 0.00% |
| JPMORGAN CHASE & CO | 115,700 | $16,896,828 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |